These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1812480)
1. [Euphylong in patients with chronic obstructive airway diseases]. Kublik A; von Wichert P Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480 [TBL] [Abstract][Full Text] [Related]
2. [Euphylong in standard dosage: comparison with an international retard preparation for twice-daily administration in recommended dosage]. Siemon G; Huber W; Maier-Stocker P Pneumologie; 1991 Nov; 45 Suppl 4():853-7. PubMed ID: 1812479 [TBL] [Abstract][Full Text] [Related]
4. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts]. Götz JK; Sauter R Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482 [TBL] [Abstract][Full Text] [Related]
5. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV; Nonikov VE; Belousov IuB Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801 [TBL] [Abstract][Full Text] [Related]
6. [Dose titration with Euphylong following prior determination of serum concentration in the steady state]. Schnabel D; von Treufels S; Oellerich M; Böttger HC; Sybrecht GW Pneumologie; 1990 Feb; 44 Suppl 1():287-8. PubMed ID: 2367392 [TBL] [Abstract][Full Text] [Related]
7. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing. Martz W; Oellerich M; Schnabel D; Sybrecht GW Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334 [TBL] [Abstract][Full Text] [Related]
8. [Therapy of obstructive respiratory tract diseases with pure theophylline retard]. Arens PJ Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic profile of a new sustained-release theophylline pellet formulation for once-daily evening administration. Steinijans VW; Sauter R; Böhm A; Staudinger H Arzneimittelforschung; 1988 Aug; 38(8A):1241-50. PubMed ID: 3190813 [TBL] [Abstract][Full Text] [Related]
10. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter]. Kaik G Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of two long-acting theophylline preparations in daily evening administration]. Holzer R Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685 [TBL] [Abstract][Full Text] [Related]
13. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease]. Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713 [TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677 [TBL] [Abstract][Full Text] [Related]
15. [Long-term stability of morning serum theophylline level in asthma patients under minimally 1-year therapy with Euphylong]. Siebert B; Kunkel G; Staudinger HW; Böhm A; Steinijans VW Pneumologie; 1991 Nov; 45 Suppl 4():848-52. PubMed ID: 1812478 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups]. Berdel D; von Berg A; Reinhardt D; Heimann G; Steinijans VW; Sauter R Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481 [TBL] [Abstract][Full Text] [Related]
17. [Prescription of Theostat 300 as a single evening dose]. Germouty J; Bida C; Moreau L Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266 [TBL] [Abstract][Full Text] [Related]
18. Oral doxophylline in patients with chronic obstructive pulmonary disease. Villani F; De Maria P; Ronchi E; Galimberti M Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999 [TBL] [Abstract][Full Text] [Related]
19. Once daily theophylline: multiple-dose comparison of an encapsulated micro-osmotic system (Euphylong) with a tablet (Uniphyllin). Steinijans VW; Schulz HU; Beier W; Radtke HW Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):438-47. PubMed ID: 3759279 [TBL] [Abstract][Full Text] [Related]
20. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations. Cova D; Cuglituri G; Rossini L; Bonfardeci G Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]